HARMONTTRA Trademark

Trademark Overview


On Tuesday, November 22, 2011, a trademark application was filed for HARMONTTRA with the United States Patent and Trademark Office. The USPTO has given the HARMONTTRA trademark a serial number of 85478826. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 20, 2014. This trademark is owned by Eli Lilly and Company. The HARMONTTRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants
harmonttra

General Information


Serial Number85478826
Word MarkHARMONTTRA
Filing DateTuesday, November 22, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 20, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 23, 2012

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants
Translation of Words in MarkThe wording "HARMONTTRA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 30, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Tuesday, January 21, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 20, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 22, 2013EXTENSION 1 GRANTED
Thursday, April 25, 2013EXTENSION 1 FILED
Tuesday, May 21, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 25, 2013TEAS EXTENSION RECEIVED
Tuesday, December 18, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 23, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 23, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 3, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 18, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 14, 2012ASSIGNED TO LIE
Wednesday, September 5, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 31, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 31, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 31, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 8, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 8, 2012NON-FINAL ACTION E-MAILED
Thursday, March 8, 2012NON-FINAL ACTION WRITTEN
Thursday, March 8, 2012ASSIGNED TO EXAMINER
Wednesday, November 30, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 25, 2011NEW APPLICATION ENTERED IN TRAM